Recent Study: Jordan Pharmaceuticals & Healthcare Report Q3 2013
As we anticipated, Jordanian pharmaceutical exports increased in 2012 due to base effects around the Arab Spring in 2011. We project exports from Jordan will slow through to 2017 as generic competition from Indian and Chinese drugmakers increases, and as multinationals address high noncommunicable disease burdens in key GCC markets. To counter these factors, we believe Jordanian drugmakers will widen their presence in Africa by driving volume sales in markets with large populations, such as Nigeria and Egypt. While the...
View full press release